Decheng Capital Management III (Cayman), LLC 13F Holdings · last filed Q3 2023
Decheng Capital Management III (Cayman), LLC reported 26 securities worth $299.64M in its SEC 13F filing for Q3 2023 (period ended 2023-09-30). Top holdings: ALPN (25.63%), ZNTL (14.06%), AURA (6.09%). Among its top 25 positions this quarter: 9 new, 1 added, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ALPN | Alpine Immune Sciences, Inc. | $76.8M | 25.63% | 6.7M | New |
| 2 | ZNTL | Zentalis Pharmaceuticals Inc. | $42.1M | 14.06% | 2.1M | Hold |
| 3 | AURA | Aura Biosciences, Inc. | $18.2M | 6.09% | 1.2M | Added |
| 4 | ROIV | ROIVANT SCIENCES LTD | $17.0M | 5.69% | 1.5M | New |
| 5 | SLRN | ACELYRIN INC(NSM) | $15.7M | 5.26% | 1.5M | Trimmed |
| 6 | RCUS | Arcus Biosciences, Inc | $15.6M | 5.21% | 869,790 | Hold |
| 7 | TXG | 10x Genomics, Inc. | $14.8M | 4.95% | 359,554 | Hold |
| 8 | ARGX | Argenx SE | $13.5M | 4.50% | 27,429 | Hold |
| 9 | PACB | Pacific Biosciences of California, Inc. | $12.2M | 4.08% | 1.5M | Hold |
| 10 | ILMN | Illumnia, Inc. | $11.1M | 3.70% | 80,859 | Hold |
| 11 | LNTH | LANTHEUS HOLDINGS INC(NMS) | $9.9M | 3.30% | 142,196 | New |
| 12 | HZNP | Horizon Therapeutics PLC | $9.1M | 3.05% | 78,900 | Hold |
| 13 | PHAT | PHATHOM PHARMACEUTICALS INC | $8.8M | 2.94% | 850,000 | Hold |
| 14 | IMGN | IMMUNOGEN INC | $6.6M | 2.20% | 415,880 | New |
| 15 | SGEN | SEAGEN INC | $4.9M | 1.63% | 23,014 | New |
| 16 | BYSI | BeyondSpring Inc. | $4.0M | 1.32% | 5.0M | New |
| 17 | HLTHQ | Cue Health Inc. | $4.0M | 1.32% | 9.0M | Hold |
| 18 | TERN | Terns Pharmaceuticals, Inc. | $3.6M | 1.20% | 714,285 | Hold |
| 19 | EQ | Equillium Inc. | $3.3M | 1.10% | 4.4M | Hold |
| 20 | WHWK | Aadi Bioscience, Inc. | $2.5M | 0.85% | 526,329 | Hold |
| 21 | ATRC | AtriCure Inc. | $2.0M | 0.68% | 46,259 | New |
| 22 | SCYX | Scynexis Inc. | $1.3M | 0.42% | 555,555 | Hold |
| 23 | MRSN | Mersana Therapeutics, Inc. | $1.1M | 0.38% | 904,268 | Hold |
| 24 | PYXS | Pyxis Oncology, Inc (formerly Apexigen) | $650,352 | 0.22% | 326,810 | New |
| 25 | WGS | GeneDx Holdings Corp. | $377,118 | 0.13% | 103,604 | New |
Source: SEC Form 13F filings · as of 2023-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR